Scarica l'app Stockscreener
419.26
2.18%
-9.36
Dopo l'orario di chiusura:
419.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$428.62
Aprire:
$429.3
Volume 24 ore:
788.19K
Relative Volume:
1.26
Capitalizzazione di mercato:
$34.33B
Reddito:
$3.84B
Utile/perdita netta:
$866.24M
Rapporto P/E:
40.43
EPS:
10.37
Flusso di cassa netto:
$792.60M
1 W Prestazione:
+0.29%
1M Prestazione:
-1.83%
6M Prestazione:
-15.55%
1 anno Prestazione:
-18.67%
Intervallo 1D:
$418.66
$432.95
Intervallo di 1 settimana:
$412.68
$432.95
Portata 52W:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Increases By 7.1% - MarketBeat
Seilern Investment Management Ltd Purchases New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Yahoo Finance
Sax Wealth Advisors LLC Purchases 617 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
RDA Financial Network Grows Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Carderock Capital Management Inc. Has $5.69 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Avanza Fonder AB Invests $2.69 Million in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Gateway Investment Advisers LLC Purchases 1,274 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Oak Thistle LLC Makes New $426,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Sets Q4 and Full Year 2024 Earnings Release Date for February 3 - StockTitan
Claro Advisors LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market - MarketWatch
IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes - Yahoo Finance
Assenagon Asset Management S.A. Buys 316,048 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
CHICAGO TRUST Co NA Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Declining Stock and Solid Fundamentals: Is The Market Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - Yahoo Finance
International Assets Investment Management LLC Sells 527,447 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - Nasdaq
IDEXX Laboratories' Quarterly Earnings Preview: What You Need To Know - Barchart
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Westwind Capital Raises Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Bath Savings Trust Co Sells 3,308 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Insight Wealth Strategies LLC Has $4.17 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly - Simply Wall St
IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
Is IDEXX Laboratories Stock Underperforming the S&P 500? - MSN
IDEXX Laboratories Inc. stock rises Friday, still underperforms market - MarketWatch
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback? - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Issues FY 2024 Earnings Guidance - MarketBeat
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX - The Manila Times
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 9.3% CAGR delivered to shareholders - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories' SWOT analysis: veterinary diagnostics leader faces market headwinds - Investing.com India
Wilmington Savings Fund Society FSB Has $999,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Franklin Resources Inc. Boosts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):